Mai Capital Management Artivion, Inc. Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in Artivion, Inc. stock. As of the latest transaction made, Mai Capital Management holds 4,550 shares of AORT stock, worth $128,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,550Holding current value
$128,583% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
176Shares Held
37.1MCall Options Held
29.9KPut Options Held
2.3K-
Black Rock Inc. New York, NY6.64MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$79.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$79 Million2.68% of portfolio
-
Macquarie Group LTD Australia, C32.74MShares$77.4 Million0.09% of portfolio
-
Morgan Stanley New York, NY2.36MShares$66.7 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.14B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...